What is AtriCure Inc (ATRC)?
AtriCure Inc is a medical device company that develops, manufactures, and markets innovative surgical devices for the treatment of atrial fibrillation and related conditions. The company’s products are designed to improve the safety and efficacy of cardiac surgical procedures, particularly those involving the heart's atria. AtriCure's portfolio includes devices for ablation, ligation, and mapping used by cardiac surgeons to treat abnormal heart rhythms. The company focuses on advancing technologies that support minimally invasive surgical techniques and enhance patient outcomes. AtriCure operates in the healthcare sector with a commitment to clinical research and collaboration with medical professionals. Its products are utilized in hospitals and surgical centers worldwide, contributing to the management of cardiac arrhythmias through surgical intervention.
AtriCure Inc Stock Price Today: Live Overview
The price today is shaped by ongoing trades, as AtriCure Inc holds a value of $29.27. The instrument has seen a trading range from $28.35 to $29.13 with a percentage change of 0% for the day.
FAQ: AtriCure Inc (ATRC)
What is the current price of ATRC stock?
The last traded price is $29.27.
Does ATRC pay dividends?
AtriCure Inc pays dividends.
Does ATRC have a formal corporate presence or regional headquarters in the UAE?
AtriCure Inc does not have an official office or subsidiary in the UAE and operates through local partners only.
What is ATRC best known for?
AtriCure Inc is most famous for its medical devices used in atrial fibrillation treatment.
What assets are typically shown together with ATRC?
Commonly shown alongside ATRC: Baxter, Bioventus Inc., Cerus Corp
Latest shares articles



